Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...

Director Russell Vought has made good on his promise to put federal workers in “trauma.” The second Trump administration’s opening salv ...

BioLineRx Ltd., a clinical-stage biopharmaceutical company specializing in oncology and rare diseases, is advancing GLIX1 as its lead asset, targeting DNA damage response in glioblastoma and other ...

What seemed like a revolutionary and reliable idea turned out to be one of GM's biggest engine-related flops.

Patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief of Neuro-Oncology & Co-Director of Brain and Spine Tumor Center, Perlmutter Cancer CenterData ...

Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited ...

By Uwais Abbubakar IdrisParadigm News International, having closely followed the evolution of Africa's health systems -- particularly the Africa Centres for Disease Control and Prevention (Africa CDC) ...

An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...

The Phase 2 study (NCT06954467) aiming to evaluate the safety and efficacy of JS207 in combination with JS007 included a safety run-in period and a randomized expansion phase, which enrolled patients ...

BBO-11818 is currently being evaluated in the Phase 1 KONQUER-101 trial in subjects with locally advanced unresectable or metastatic KRAS-mutant ...

STRO-006 and STRO-227 show meaningful, dose-dependent antitumor activity across solid tumor models Presentation of TROP2-targeted immunostimulatory ADC program partnered with Astellas highlights the ...

Acute perceptual effects and long-term auditory health are separate questions. A cross-sectional NHANES analysis by Qian and ...